Nunzia Pharmaceutical Company filed its 10-K on Apr 15, 2022 for the period ending Dec 31, 2021. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.3M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- NUNZ Stock
- News Nunzia Pharmaceutical Company
- Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt